Drugs / Peptide vaccine for URLC10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00624182 | Feb 2008 → Apr 2016 | bile duct cancer | Akita University Hospital | Suspended | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peptide vaccine for URLC10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00624182 ↗ |
| Modality | Vaccine | “Peptide vaccine for URLC10” NCT00624182 ↗ |
| Route | Subcutaneous | “administered by subcutaneous injection” NCT00624182 ↗ |